01/12/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/12/2020. This 10-page document is intended for clinicians taking care of hospitalized adult and pediatric patients with severe acute respiratory infection (SARI) when novel coronavirus (nCoV) infection is suspected. It is not meant to replace clinical judgment or specialist consultation, but rather to strengthen clinical management of these patients and provide to up-to-date guidance. Best practices for SARI, including infection prevention and control (IPC) and optimized supportive care for severely ill patients, are essential. (PDF)
Surveillance Case Definitions for Human Infection with Novel Coronavirus (nCoV): Interim Guidance V1
01/11/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/11/2020. This one-page document summarizes World Health Organization (WHO) recommendations for surveillance of the novel coronavirus (nCoV) recently identified in Wuhan, China (2019-nCoV). WHO will update these recommendations as new information becomes available on the situation in Wuhan, China. This interim guidance was adapted from WHO’s guidance materials published for Middle East respiratory syndrome coronavirus (MERS-CoV). (PDF)
01/10/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/10/2020. The purpose of this eight-page document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected cases of pneumonia associated with a novel coronavirus identified in Wuhan, China. It covers specimen collection and shipment, effective usage of global laboratory networking, testing in reference laboratories, and reporting of cases and test results. (PDF)
01/09/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/9/2020. This web page provides answers to 11 questions about coronaviruses, a large family of viruses that are known to cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Topics include what a novel coronavirus is, if there is a vaccine for coronaviruses, and if health workers are at risk from a novel coronavirus. (Text)
01/09/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/9/2020. The main aim of this five-page tool is to better understand existing capacities in the area of detection and response to a novel coronavirus (nCoV) that is zoonotic and causes respiratory disease. The tool was developed with other coronaviruses, such as SARS-CoV and MERS-CoV, in mind and in consultation with member states. This information will help national authorities to identify main gaps, perform risk assessments, and plan for additional investigations, response, and control actions. (PDF)
01/09/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/9/2020. This four-page table is a disease commodity package for novel coronavirus that provides information about surveillance, prevention and control, case management, key outbreak control activities considered for material supply, and personal protective equipment. (PDF)
01/01/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/2020. This three-page guidance is intended for healthcare workers, healthcare managers, and infection prevention and control teams, detailing principles of infection prevention and control strategies associated with health care with suspected novel coronavirus (nCoV). It discusses duration of contact and droplet precautions for nCoV infection, and collection and handling of laboratory specimens from patients with suspected nCoV. (PDF)
01/01/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/2020. This three-page document provides World Health Organization checklists for risk communication and community engagement (RCCE) readiness and initial response for novel coronaviruses (nCoV) recently identified in Wuhan, China (2019-nCoV). Its objective is to provide actionable guidance for countries to implement effective RCCE strategies that will help protect the public’s health in the early response to nCoV. It includes recommended RCCE goals and actions for countries preparing for nCoV cases and for countries that have confirmed nCoV cases. (PDF)
01/01/2020 12:00 AM EST
Source: National Academies Press (NAP). Published: 1/2020. Drawing on lessons learned during the 2017 hurricanes, this 106-page report explores future strategies to improve supply chain management in disaster situations. Focusing on the supply chains for food, fuel, water, pharmaceutical, and medical supplies, the recommendations of the report will assist the Federal Emergency Management Agency, as well as state and local officials, private sector decision makers, civic leaders, and others who can help ensure that supply chains remain robust and resilient in the face of natural disasters. (Text)
01/01/2020 12:00 AM EST
Source: World Economic Forum. Published: 1/2020. This 18-page report, written in collaboration with the Nuclear Threat Initiative (NTI) and endorsed by an international expert working group, recommends a global system for synthetic DNA screening practices by developing an international, cost-effective, and sustainable mechanism to prevent illicit practices and misuse of these practices. The new framework improves the existing voluntary guidelines because it standardizes screening processes, is accessible to new players in the market, and provides valuable feedback data to evaluate the screening – all at lower cost. (PDF)
.png)
No hay comentarios:
Publicar un comentario